Related Experiment Video
Updated: May 9, 2026
14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Revascularization surgery as a treatment concept for heart failure
J Ennker1, S Bauer, I C Ennker
1Mediclin Heart Institute Lahr/Baden, Lahr, Germany ; University Witten-Herdecke, Faculty of Health, School of Medicine.
Summary
Revascularization surgery improves outcomes for patients with ischemic cardiomyopathy and viable myocardium. Late gadolinium enhancement cardiovascular magnetic resonance accurately predicts functional recovery, guiding treatment decisions for heart failure.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Imaging
Background:
- Ischemic cardiomyopathy presents a poor prognosis for heart failure patients without effective treatment.
- Coronary artery revascularization is an established treatment for patients with viable ischemic myocardium.
- Predicting regional functional recovery is crucial for assessing myocardial viability and guiding revascularization indications.
Purpose of the Study:
- To highlight the role of late gadolinium enhancement cardiovascular magnetic resonance in assessing myocardial viability.
- To discuss the predictors of survival and the impact of various revascularization strategies.
- To explore advancements in surgical techniques and medical therapies for ischemic cardiomyopathy.
Main Methods:
- Utilizing late gadolinium enhancement cardiovascular magnetic resonance to assess myocardial scar burden.
- Analyzing studies on predictors of survival and graft selection in revascularization surgery.
- Reviewing conventional, off-pump, minimal extracorporeal circulation, and hybrid revascularization approaches.
Main Results:
- The transmural extent of myocardial scar, as determined by late gadolinium enhancement, predicts segmental functional recovery.
- Coronary artery revascularization has demonstrated superiority in patients with poor left ventricular function.
- Various surgical and medical strategies exist, with ongoing improvements in techniques and outcomes.
Conclusions:
- Late gadolinium enhancement cardiovascular magnetic resonance is the gold standard for assessing myocardial viability and guiding revascularization in ischemic cardiomyopathy.
- Surgical revascularization, including advanced techniques, offers significant benefits for selected patients.
- Future directions focus on less invasive, safer coronary artery bypass grafting and novel therapeutic approaches.
Keywords:
coronary artery bypass graftingheart failurehybrid revascularisationleft ventricular reconstructionMore Related Videos
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...